Skip to main content

Chair’s Message

Ege T. Kavalali, Ph.D.


Ege T. Kavalali, Ph.D.
Professor & Acting Chair, Department of Pharmacology
William Stokes Chair In Experimental Therapeutics



I am honored to welcome you to the Department of Pharmacology at Vanderbilt. We are one of the most distinguished Pharmacology departments in the country and one that has incredible potential to advance basic science and contribute to urgently-needed drug development in the coming years.

Our research interests include five major areas:

  • signal transduction
  • neuroscience
  • bioactive lipid metabolism
  • genetic basis of cardiovascular dysfunction
  • drug metabolism

Molecules under investigation include G-protein coupled receptors (rhodopsin, adrenergic, serotonin and receptors), heterotrimeric G-proteins, ion channels, transporters and regulatory proteins such as arrestins, protein kinases and protein phosphatases.  We provide training focused on critical thinking to promote innovation, scholarship and integrity.  To this end, we foster creativity, collegiality, and leadership.

DEI Mission Statement

The Department of Pharmacology at Vanderbilt University is committed to ensuring that all students, faculty, staff, visitors, and persons feel supported and welcomed. Though often not discussed, systems of inequality, oppression, and injustice exist within academia and shape, whether explicitly or implicitly, our language, decision-making, and priorities.

The Department, with the support of its Diversity, Equity, and Inclusion committee, is dedicated to supporting historically marginalized groups in addition to unlearning the systems that have contributed to this marginalization. These systems include (but are not limited to): racism and white supremacy, xenophobia, classism, sexism, ableism, and heterosexism. We also aim to create new infrastructure for which minority identities are uplifted and their voices are heard. These minority identities may include (but, again, are not limited to): racial and ethnic minority identities, sexual and gender minority identities, low-income socioeconomic backgrounds, and non-English language backgrounds.

With your help, we will improve the Department of Pharmacology’s diversity, inclusivity, and equity of all persons.

Pharmacology in the News

Potential protection from atherosclerosis

by Bill Snyder PON1 (paraoxonase 1), an enzyme associated with high-density lipoprotein (HDL), breaks down lipid peroxides, h...

Research Snapshot: Discovery points to ketamine’s long-term antidepressant effects

THE IDEA Building on recent research confirming how ketamine induces rapid antidepressant action, Professor of Pharmacology Lisa...

Nature’s “recycler” could reduce heart disease risk: study

From left, MacRae Linton, MD, Huan Tao, MD, PhD, Jonathan Brown, MD, and colleagues have discovered a potential new target for p...

Personalized Structural Biology aids cancer treatment decisions

by Bill Snyder Cancer specialists at Vanderbilt University Medical Center, in partnership with biochemists and structural bio...

New faculty Rick Sando: A better understanding of brain circuitry

MyVU is spotlighting a select group of new faculty for 2020-21. Read more profiles in the series. By Lorena Infante Lara Our bra...

Cohen Fund bolsters Siciliano’s memory research

  by Bill Snyder Cody Siciliano, PhD, assistant professor of Pharmacology in the Vanderbilt University School of Medi...

New clue to Alzheimer’s disease

by Bill Snyder Reduced expression of Dlgap2, a gene important in signaling across the synapse between nerve cells, is associa...

Assembling cell power plant machinery

by Leigh MacMillan Mitochondrial complex II is a four-subunit protein machine located in the mitochondrial membrane that link...

‘Scavenger’ molecule may point to new atherosclerosis treatment

From left, Huan Tao, MD, PhD, Sean Davies, PhD, Jiansheng Huang, PhD, and MacRae Linton, MD, led the study that identified a pot...

vu photo
A potential new targeted therapy for metastatic melanoma

By Wendy Bindeman Melanoma is the most common of all cancers. The American Cancer Society estimates that over 100,000 new melan...

Siciliano wins Fay/Frank Seed Grant and Alkermes Pathways Research Award

By Jenna Somers Cody Siciliano (Vanderbilt University) Assistant Professor of Pharmacology Cody Siciliano has been awarded the F...

New tools to study bioactive lipids

by Leigh MacMillan NAEs are bioactive lipid molecules that appear to play roles in energy balance, inflammation, stress respo...